TREATMENT PATTERNS IN MEDICAID BENEFICIARIES WITH SCHIZOPHRENIA REACHING STABILIZED MAINTENANCE WITH ONCE-MONTHLY PALIPERIDONE PALMITATE THERAPY

被引：1
|
作者：
Pilon, D. [1 ]
Muser, E. [2 ]
Emond, B. [1 ]
Xiao, Y. [1 ]
Amos, T. [2 ]
Lefebvre, P. [1 ]
Benson, C. [2 ]
机构：
[1] Grp Anal Ltee, Montreal, PQ, Canada
[2] Janssen Sci Affairs LLC, Titusville, NJ USA
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.1868
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMH82
引用
收藏
页码：A196 / A196
页数：1
相关论文
共 50 条
  • [31] PSYCHOSOCIAL AND OVERALL EFFECTIVENESS OF ARIPIPRAZOLE ONCE-MONTHLY VS. PLACEBO ONCE-MONTHLY FOR MAINTENANCE TREATMENT IN SCHIZOPHRENIA
    Baker, R.
    Carson, W. H.
    Perry, P.
    Sanchez, R.
    Jin, N.
    McQuade, R. D.
    Kane, J.
    Fleischhacker, W. W.
    EUROPEAN PSYCHIATRY, 2013, 28
  • [32] Long-term tolerability of once-monthly injectable paliperidone palmitate in subjects with recently diagnosed schizophrenia
    Sliwa, Jennifer Kern
    Bossie, Cynthia A.
    Fu, Dong-Jing
    Turkoz, Ibrahim
    Alphs, Larry
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2012, 8 : 375 - 385
  • [33] PROJECTING THE ECONOMIC OUTCOMES OF SWITCHING PATIENTS WITH SCHIZOPHRENIA FROM ORAL ATYPICAL ANTIPSYCHOTICS TO ONCE-MONTHLY PALIPERIDONE PALMITATE AND ONCE-EVERY-THREE-MONTHS PALIPERIDONE PALMITATE
    Lin, D.
    Morrison, L.
    Pilon, D.
    Benson, C.
    Ghelerter, I
    Vermette-Laforme, M.
    Lefebvre, P.
    VALUE IN HEALTH, 2021, 24 : S129 - S129
  • [34] Paliperidone Palmitate Once-Monthly Treatment in Recent Onset and Chronic Illness Patients With Schizoaffective Disorder
    Bossie, Cynthia A.
    Turkoz, Ibrahim
    Alphs, Larry
    Mahalchick, Lucy
    Fu, Dong-Jing
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 2017, 205 (04) : 324 - 328
  • [35] Real-World Analysis of Switching Patients with Schizophrenia from Oral Risperidone or Oral Paliperidone to Once-Monthly Paliperidone Palmitate
    Charmi Patel
    Bruno Emond
    Marie-Hélène Lafeuille
    Aurélie Côté-Sergent
    Patrick Lefebvre
    Neeta Tandon
    Antoine C. El Khoury
    Drugs - Real World Outcomes, 2020, 7 : 19 - 29
  • [36] Real-World Analysis of Switching Patients with Schizophrenia from Oral Risperidone or Oral Paliperidone to Once-Monthly Paliperidone Palmitate
    Patel, Charmi
    Emond, Bruno
    Lafeuille, Marie-Helene
    Cote-Sergent, Aurelie
    Lefebvre, Patrick
    Tandon, Neeta
    El Khoury, Antoine C.
    DRUGS-REAL WORLD OUTCOMES, 2020, 7 (01) : 19 - 29
  • [37] CHARACTERISTICS OF ADULT MEDICAID BENEFICIARIES WITH SCHIZOPHRENIA TREATED WITH PALIPERIDONE PALMITATE AND PREDICTORS OF TREATMENT CONTINUITY
    Maiese, B. A.
    Montejano, L. B.
    Smith, D. M.
    Clancy, Z.
    Pesa, J. A.
    VALUE IN HEALTH, 2013, 16 (03) : A69 - A69
  • [38] COST EFFECTIVENESS ANALYSIS OF ARIPIPRAZOLE ONCE-MONTHLY VERSUS PALIPERIDONE PALMITATE IN SPAIN
    Sapin, C.
    Gimeno de la Fuente, V
    Blancher, P.
    Beillat, M.
    VALUE IN HEALTH, 2015, 18 (07) : A410 - A410
  • [39] The effect of aripiprazole once-monthly 300 mg in maintenance therapy for schizophrenia
    Suzuki, Hidenobu
    Hibino, Hiroyuki
    Takaya, Atsuhiko
    Inoue, Yuichi
    ASIAN JOURNAL OF PSYCHIATRY, 2020, 47
  • [40] Adherence, healthcare resource utilization and Medicaid spending associated with once-monthly paliperidone palmitate versus oral atypical antipsychotic treatment among adults recently diagnosed with schizophrenia
    Dominic Pilon
    Erik Muser
    Patrick Lefebvre
    Rhiannon Kamstra
    Bruno Emond
    Kruti Joshi
    BMC Psychiatry, 17
12345